v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue $ 3,329 $ 3,049 $ 9,361 $ 7,170
Cost of revenue 1,643 1,242 4,825 2,836
Gross profit 1,686 1,807 4,536 4,334
Operating expenses:        
Sales and marketing 1,742 1,685 5,212 5,265
Research and development 936 618 2,855 1,930
General and administrative 2,662 2,293 7,589 6,415
Total operating expenses 5,340 4,596 15,656 13,610
Loss from operations (3,654) (2,789) (11,120) (9,276)
Other (expense) income, net:        
Interest expense (34) (24) (90) (77)
Gain on revaluation of warrant liabilities 112 1,125 1,011 2,011
Gain on forgiveness of note payable 0 0 0 1,099
Unrealized loss on foreign exchange (732) (268) (1,704) (640)
Other income (expense), net 4 (2) 1 (18)
Total other (expense) income, net (650) 831 (782) 2,375
Net loss (4,304) (1,958) (11,902) (6,901)
Other comprehensive income 652 261 1,503 601
Comprehensive loss $ (3,652) $ (1,697) $ (10,399) $ (6,300)
Net loss per share applicable to common shareholders, basic (in dollars per share) $ (0.33) $ (0.15) $ (0.92) $ (0.57)
Net loss per share applicable to common shareholders, diluted (in dollars per share) $ (0.33) $ (0.17) $ (0.92) $ (0.62)
Weighted average number of shares outstanding, basic (in shares) 13,071 12,661 12,896 12,029
Weighted average number of shares outstanding, diluted (in shares) 13,071 12,710 12,896 12,133

Source